CXCR4 in acute myelogenous leukemia (AML): When too much attraction is bad for you

Leukemia Research

Volumn 33, Issue 6, 2009, Pages 747-748

  Burger, Jan A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; FOCAL ADHESION KINASE; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; VERY LATE ACTIVATION ANTIGEN 4;

ACUTE GRANULOCYTIC LEUKEMIA; CELL MOTILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; EDITORIAL; HEMATOPOIETIC STEM CELL; HUMAN; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; STEM CELL MOBILIZATION;

HUMANS; LEUKEMIA, MYELOID, ACUTE; PROGNOSIS; RECEPTORS, CXCR4;

EID: 63349109694     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.007     Document Type: Editorial

References (12)

1. Burger J.A., and Burkle A. The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target. Br J Haematol 137 (2007) 288-296
2. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
3. Sugiyama T., Kohara H., Noda M., et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25 (2006) 977-988
4. Peled A., Petit I., Kollet O., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
5. Sipkins D.A., Wei X., Wu J.W., et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435 (2005) 969-973
6. Wright D.E., Bowman E.P., Wagers A.J., et al. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 195 (2002) 1145-1154
7. Burger J.A., Spoo A., Dwenger A., et al. CXCR4 chemokine receptors (CD184) and alpha4beta1 integrins mediate spontaneous migration of human CD34+ progenitors and acute myeloid leukaemia cells beneath marrow stromal cells (pseudoemperipolesis). Br J Haematol 122 (2003) 579-589
8. Konopleva M., Konoplev S., Hu W., et al. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 16 (2002) 1713-1724
9. Spoo A.C., Lubbert M., Wierda W.G., et al. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood 109 (2007) 786-791
10. Rombouts E.J., Pavic B., Lowenberg B., et al. Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood 104 (2004) 550-557
11. Konoplev S., Rassidakis G.Z., Estey E., et al. Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype. Cancer 109 (2007) 1152-1156
12. Wells D.A., and Loken M.R. Flow cytometric mean fluorescence intensity: the biophysics behind the number. Leuk Res 32 (2008) 845-846